Sold as Halotex. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 2 applications for Haloprogin (sold as Halotex), first approved Aug 6, 1971, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Aug 6, 1971 | HalotexNDA 16942 · New molecular entity | Westwood Squibb | 4 | Discontinued |
| Aug 6, 1971 | HalotexNDA 16943 · New dosage form | Westwood Squibb | 2 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
